SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-10-131918
Filing Date
2010-06-03
Accepted
2010-06-03 12:19:26
Documents
3
Group Members
ASTELLAS US HOLDING, INC.RUBY ACQUISITION, INC.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 16 TO SCHEDULE TO-T dsctota.htm SC TO-T/A 54830
2 PRESS RELEASE ISSUED BY ASTELLAS dex99a5t.htm EX-99.(A)(5)(T) 12026
3 GRAPHIC g33365g98u47.jpg GRAPHIC 23632
  Complete submission text file 0001193125-10-131918.txt   101597
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-37954 | Film No.: 10875042
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-T/A